Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-α

Circulation

Volumn 104, Issue 6, 2001, Pages 676-681

  Stetson, Sonny J ^a   Perez Verdia, Ale ^a   Mazur, Wojceich ^a   Farmer, John A ^a   Koerner, Michael M ^a   Weilbaecher, Donald G ^a   Entman, Mark L ^a   Quiñones, Miguel A ^a   Noon, George P ^a   Torre Amione, Guillermo ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Growth substances; Hypertrophy; Transplantation

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; LUNG TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0035822645     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3101.093765     Document Type: Article

References (23)

1. Restrictive physiology late after transplantation adversely affects survival
2. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth official report: 1999
3. Expression and functional significance of tumor necrosis factor receptors in human myocardium
4. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart
5. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart
6. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
7. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α
8. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α
9. The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation
10. Tumor necrosis factor-alpha is persistently expressed in cardiac allografts in the absence of histological or clinical evidence of rejection
11. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting
12. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: Results of the SOLVD echocardiography substudy
13. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections
14. Polarization microscopic studies of connective tissue stained with picro-sirius red FBA
15. Are picro-dye reactions for collagens quantitative? Chemical and histochemical considerations
16. Quantification of immunohistochemistry using an image analyser: Correlation with hormone concentrations in pituitary adenomas
17. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group: The International Society for Heart Transplantation
18. Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation
19. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
20. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy
21. Prevention of cardiac hypertrophy in mice by calcineurin inhibition
22. Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes
23. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro